ArticleCancers2020

The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer.

Rachael M Orlandella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.